Actively Recruiting
Pilot Study of Low-Intensity Oscillatory Magnetic Therapy Using the Oncomagnetic Device in Adults with Newly Diagnosed Glioblastoma Multiforme A Personalized Exposure-Time Escalation Approach
Led by BioTex, Inc. · Updated on 2026-06-02
30
Participants Needed
6
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and performance of the Oncomagnetic Device, a portable wearable noninvasive magnetic device, in patients newly diagnosed with Glioblastoma Multiforme GBM. This non-randomized, multicenter, open-label clinical investigation uses an exposure-time escalation approach to understand how the device works over increasing durations of daily use. The study aims to provide important information on the devices clinical safety and effectiveness in this patient population. Participants will start using the Oncomagnetic Device for 4 hours per day. If no issues arise after 2 weeks, the daily use will increase to 6 hours, then to 8 hours after another 2 weeks without problems. If any device-related issues occur, the usage time may be reduced by 4 hours per day, with a minimum use of 2 hours daily, adjusted as needed. This personalized escalation continues throughout the study. During the study, participants will be monitored for safety and device performance for at least 6 months, with some evaluations extending up to 3 years. Assessments include clinical reviews and MRI scans to track disease status and any side effects. The main outcome is to assess safety within 6 months, while secondary outcomes focus on device performance over 6 months and up to 3 years. Participants must comply with all procedures and be available for the duration of the investigation.
CONDITIONS
Brief Title
Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial
Research Team
A
Ashok Gowda
M
Madeline Meier
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here